TABLE 2.

Summary of L2 ELISA-screened patient sera^a

^aShaded rows show the patients (n = 7/19) whose serum samples displayed reactivity for full-length HPV16 L2 by both ELISA and Western blot. Serum numbers 1 to 18 were from the CATCH study near Hyderabad, Andhra Pradesh (AP), India, and serum 19 was from the CIN cohort study at Johns Hopkins University, Baltimore, MD, USA. Neg, negative; ND, not done; Y, yes; N, no; N*, serum was limiting, and Western blot analysis could be done only at a dilution of 1:5,000.